How data centers can take full advantage of the operational efficiencies controls and automation systems can create, fully leveraging their BMS tools to boost their bottom line Building management ...

US pharma major Bristol Myers Squibb has announced positive data from the pivotal Phase III POETYK PsA-2 trial evaluating the ...

Why have BMS investors been anything but positive about acquiring 2seventy? The answer stems from uncertainty over how ...

Founded in 2004, CE-LINK is a leader in portable power solutions, specializing in innovative and high-quality energy products. Known for its commitment to safety, reliability, and sustainability, ...

The new data gives BMS an opportunity to extend its lead over Cytokinetics, in pursuit of mavacamten with its rival cardiac myosin inhibitor CK-274 which cleared a phase 2 trial last year and is ...

Three months after Bristol Myers Squibb revealed the success of two phase 3 trials of its oral targeted therapy Sotyktu in ...

Late-stage data also showed that Johnson & Johnson’s icotrokinra was superior to Bristol Myers Squibb’s Sotyktu at clearing ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Johnson & Johnson’s once-daily oral peptide has bested Bristol Myers Squibb’s reigning oral psoriasis med Sotyktu in a ...